$heff's $tation of $tocks & $olid DD

[umiak]

NAVB-"A majority of institutions ordering Lymphoseek are purchasing multiple doses. Most encouraging are some key empirical observations. Let me repeat most encouraging are some key empirical observations. We are seeing repeat orders from the significant numbers of accounts. A majority of institutions ordering Lymphoseek are purchasing multiple doses.

We've witnessed good conversion to formulary placement and we're seeing good period-on-period growth.

I was fortunate to be able to spend a number of days in the field with customers and sales reps and I am pleased to report that what I saw and heard was extremely encouraging.

We're actively selling the product, people are buying it and procedures are being conducted effectively and efficiently. The feedback has been outstanding especially in those measures that are critically important in launch of a novel product like Lymphoseek , such as recognition of differential product performance, customer satisfaction and positive physician and institutional endorsements.

We've also seen positive trends in formulary placement it's important to note that formulary placement, for Nuclear Medicine product is not necessary at many institutions approval of new Nuclear Medicine products is typically handled outside of the Central Hospital Pharmacy Channels. While in institutions where formulary placement is required we're seeing good conversion.

At least a half dozen top-tier institutions in key markets in New York, California, Texas and Ohio have already put Lymphoseek on formulary and two premier academic institutions have already made the decision to switch exclusively to Lymphoseek as the radiopharmaceutical of choice. And this is all in just a few first few weeks of launch.

Good experiences are also being reported on a number of fronts for Lymphoseek . For lymph node liquidation and sensitivity customers are commenting that Lymphoseek 's rapid injection site clearance and lymph node retention are resulting in scheduling efficiencies and productivity gains."